Recommendations on diagnosis and initial treatment of patients with transplant-eligible high-risk multiple myeloma by the British Society of Haematology/UK Myeloma Society
https://t.co/pRIcPEEUwr
@MyMKaiser@DrSStern@JennerMatthew@UKMyelomaSoc
Delighted that the @BritSocHaem@UKMyelomaSoc Good Practice Paper on the treatment of high risk transplant-eligible myeloma is now published. Many thanks to @MyMKaiser for his great input. #mmsm
British Journal of Haematology | Wiley Online Library https://t.co/k3xBCOhthv
Everyone must come! Great science, great city, great food and you get to hang out with cool #mmsm Canadian colleague hosts :) we look forward to welcoming everyone.
Many thanks, very kind. Deeply feel we should discuss the value of extended upfront risk molecular diagnostic tests more in #myeloma , not only price. We might find that they will help allocate other rare resources like imaging or MRD tests throughout treatment phases better.
$50 billion a year is spent on failed cancer drug development by the pharma industry. Our new paper is a case study on what goes wrong. @consiliumsci @Jhickmana
https://t.co/jdkIdFpZae
If you missed an excellent live debate organised by @TranspariMED on how the UK trial transparency system can be implemented in other countries, watch here https://t.co/ZciLVwEo2w @cmarctaylor@Strech_Da@NDevito1@HRA_Latest @matt_westmore @berlinnovation @EricLow71 @Jhickmana
Will be very interesting to see how this will work in practice - a fantastic, extremely scalable technology. And of course hoping #myeloma patients may be included as well! @BioNTech_Group@NCRI_partners#MMsm
https://t.co/7MSAAqCCHX
@kennycairns @LeedsCTRU The Leeds CTRU are the bedrock behind all the best UK myeloma trials, and they don't get the credit, recognition and protection they deserve. It's great that they get the recognition they deserve in this paper.
@kennycairns @LeedsCTRU The Leeds CTRU is the bedrock of all the best UK trials. I suspect they don't get the credit, protection and funding they deserve. Seeing them get the recognition they deserve in this paper is great.